IRIS Institutional Research Information System - OPENBS Open Archive UniBS

LEALI, Daria
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.908
EU - Europa 1.539
AS - Asia 1.205
SA - Sud America 229
Continente sconosciuto - Info sul continente non disponibili 86
AF - Africa 47
OC - Oceania 5
Totale 6.019
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.831
PL - Polonia 503
CN - Cina 435
SG - Singapore 362
DE - Germania 283
UA - Ucraina 208
BR - Brasile 185
HK - Hong Kong 121
GB - Regno Unito 109
VN - Vietnam 84
FI - Finlandia 83
IT - Italia 82
RU - Federazione Russa 70
FR - Francia 56
TR - Turchia 42
CA - Canada 41
ES - Italia 37
IE - Irlanda 36
IN - India 34
BD - Bangladesh 24
SE - Svezia 18
CZ - Repubblica Ceca 15
IR - Iran 15
JP - Giappone 13
AR - Argentina 12
ZA - Sudafrica 12
MX - Messico 11
ID - Indonesia 9
CO - Colombia 8
EC - Ecuador 8
PK - Pakistan 8
KR - Corea 7
MA - Marocco 7
NO - Norvegia 6
TT - Trinidad e Tobago 6
EG - Egitto 5
ET - Etiopia 5
IL - Israele 5
LT - Lituania 5
SA - Arabia Saudita 5
UZ - Uzbekistan 5
AT - Austria 4
AU - Australia 4
BE - Belgio 4
CL - Cile 4
HN - Honduras 4
MU - Mauritius 4
NG - Nigeria 4
NL - Olanda 4
PY - Paraguay 4
TH - Thailandia 4
VE - Venezuela 4
AZ - Azerbaigian 3
BG - Bulgaria 3
DZ - Algeria 3
GE - Georgia 3
GP - Guadalupe 3
GT - Guatemala 3
IQ - Iraq 3
PH - Filippine 3
SK - Slovacchia (Repubblica Slovacca) 3
EE - Estonia 2
JO - Giordania 2
KG - Kirghizistan 2
LK - Sri Lanka 2
MY - Malesia 2
NI - Nicaragua 2
PA - Panama 2
RO - Romania 2
TW - Taiwan 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BO - Bolivia 1
BZ - Belize 1
CG - Congo 1
CH - Svizzera 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
GH - Ghana 1
GR - Grecia 1
GY - Guiana 1
HU - Ungheria 1
JM - Giamaica 1
KE - Kenya 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
MD - Moldavia 1
MK - Macedonia 1
MZ - Mozambico 1
NP - Nepal 1
NZ - Nuova Zelanda 1
OM - Oman 1
PE - Perù 1
PS - Palestinian Territory 1
SN - Senegal 1
SV - El Salvador 1
Totale 5.930
Salva come PNG Salva come JPEG
Città #
Warsaw 502
Fairfield 259
Ashburn 253
Singapore 192
Woodbridge 192
San Jose 186
Jacksonville 159
Houston 155
Ann Arbor 133
Hong Kong 114
Beijing 108
Seattle 106
Wilmington 106
Chandler 92
Cambridge 84
Council Bluffs 77
Los Angeles 66
Princeton 64
The Dalles 55
Helsinki 50
Nanjing 46
New York 41
Dearborn 38
Dublin 37
Columbus 36
Dallas 35
Madrid 31
Lauterbourg 30
Istanbul 29
Santa Clara 29
Jinan 27
San Francisco 25
Shanghai 24
Brescia 23
Chicago 21
Dong Ket 21
Porto Alegre 20
Ho Chi Minh City 19
Des Moines 18
Nanchang 18
Buffalo 17
São Paulo 17
Shenyang 16
Changsha 15
Hebei 14
Jiaxing 14
Orem 14
Brno 13
Lancaster 13
Montreal 13
Phoenix 13
Brooklyn 12
Hanoi 12
Munich 12
Stockholm 12
Tokyo 12
London 11
Redondo Beach 11
San Mateo 11
Hangzhou 10
Milan 10
Moscow 10
Johannesburg 9
Poplar 9
Rio de Janeiro 9
Chennai 8
Frankfurt am Main 8
Kunming 8
North Bergen 8
Nuremberg 8
San Diego 8
Nürnberg 7
Jakarta 6
Kilburn 6
Oslo 6
Tehran 6
Tianjin 6
Verona 6
Atlanta 5
Bahir Dar 5
Biên Hòa 5
Campinas 5
Denver 5
Haikou 5
Miami 5
Ningbo 5
Toronto 5
Uberlândia 5
Zhengzhou 5
Abuja 4
Ardabil 4
Augusta 4
Bangkok 4
Boardman 4
Chaguanas 4
Glasgow 4
Kocaeli 4
Monmouth Junction 4
Paris 4
Santiago 4
Totale 4.020
Salva come PNG Salva come JPEG
Nome #
Long Pentraxin-3 inhibits FGF-dependent angiogenesis andgrowth of steroid hormone-regulated tumors 370
Nanoliter contact angle probes tumor angiogenic ligand-receptor protein interactions 321
Fibroblast growth factor 2-antagonist activity of a long-pentraxin 3-derived antiangiogenic pentapeptide. 317
Gremlin is a novel agonist of the major pro-angiogenic receptor VEGFR2 311
The pattern recognition receptor PTX3 as an angiostatic epithelial/stromal FGF-targeting inhibitor in hormonal cancers 258
A Pro-inflammatory Signature Mediates FGF2-induced Angiogenesis 241
Anti-FGF2 approaches as a strategy to compensate resistance to anti-VEGF therapy: long-pentraxin 3 as a novel antiangiogenic FGF2-antagonist. 239
ANTI-ANGIOGENIC ACTIVITY OF A NEUTRALIZING HUMAN SINGLE-CHAIN ANTIBODY FRAGMENT AGAINST FIBROBLAST GROWTH FACTOR RECEPTOR 1 231
Fibroblast growth factor-2 antagonist and Antiangiogenic activity of long-pentraxin 3-derived synthetic peptides 220
A Pro-inflammatory Signature Mediates FGF2-induced Angiogenesis 217
Long Pentraxin-3 As An Epithelial-Stromal Fibroblast Growth Factor-Targeting Inhibitor In Prostate Cancer. 217
Long pentraxin-3 inhibits epithelial-mesenchymal transition in melanoma cells. 212
Role of Nanomechanics in Canonical and Noncanonical Pro-angiogenic Ligand/VEGF Receptor-2 Activation 188
Examining new models for the study of autocrine and paracrine mechanisms of angiogenesis through FGF2-transfected endothelial and tumour cells. 184
Fibroblast growth factor-2 in angiogenesis 156
Exploiting Surface Plasmon Resonance (SPR) Technology for the Identification of Fibroblast Growth Factor-2 (FGF2) Antagonists Endowed with Antiangiogenic Activity 153
Isolation and characterization of a neutralizing and anti-angiogenic anti-FGFR1 single chain antibody 151
Inflammatory cells and chemokines sustain FGF2-induced angiogenesis 148
Heparin derivatives as angiogenesis inhibitors 147
Osteopontin (Eta-1) and fibroblast growth factor-2 cross-talk in angiogenesis. 146
Osteopontin overexpression inhibits in vitro re-endothelialization via integrin engagement. 141
Modulation of fibroblast growth factor-2 receptor binding, signaling, and mitogenic activity by heparin-mimicking polysulfonated compounds 141
VEGFR2 activation mediates the pro-angiogenic activity of BMP4 141
Role of inflammation in FGF2-driven angiogenesis 135
Osteopontin overexpression inhibits in vitro re-endothelialization via integrin engagement 134
EXPLOTING SURFACE PLASMON RESONANCE (SPR) TECHNOLOGY FOR THE IDENTIFICATION OF FIBROBLAST GROWTH FACTOR-2 (FGF2) ANTAGONISTS ENDOWED WITH ANTI-ANGIOGENIC ACTIVITY 116
Malnutrition Prevention after Allogeneic Hematopoietic Stem Cell Transplantation (alloHSCT): A Prospective Explorative Interventional Study with an Oral Polymeric Formulation Enriched with Transforming Growth Factor Beta 2 (TGF-β2) 115
FGF2- Antagonist activity of long pentraxin-3 115
FGF2-Antagonist activity of long pentraxin-3 related peptides 113
Heparin derivatives and semysynthetic biotechnological heparins as angiogenesis inhibitors 112
Examining new models for the study of autocrine and paracrine mechanisms of angiogenesis through FGF2-transfected endothelial and tumor cells 110
THE CYSTINE-KNOT PROTEIN GREMLIN IS A NOVEL AGONIST OF THE MAJOR PRO-ANGIOGENIC RECEPTOR VEGFR2 110
Cutting Edge: IL-1beta Mediates the Proangiogenic Activity of Osteopontin-Activated Human Monocytes 109
Totale 6.019
Salva come PNG Salva come JPEG
Categoria #
all - tutte 24.274
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 24.274
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022204 0 0 0 0 1 14 16 14 10 51 23 75
2022/2023253 37 11 23 14 14 54 0 26 31 2 20 21
2023/2024333 21 38 41 17 20 26 15 12 62 13 8 60
2024/2025682 16 11 7 85 62 58 72 52 81 33 110 95
2025/20261.438 142 156 103 180 238 95 252 33 66 113 47 13
2026/2027350 52 58 93 139 8 0 0 0 0 0 0 0
Totale 6.019